Quality of clinical direct oral anticoagulant prescribing and identification of risk factors for inappropriate prescriptions

被引:12
|
作者
Zhang, Zhu Xian [1 ]
van de Garde, Ewoudt M. W. [1 ,2 ]
Sohne, Maaike [3 ]
Harmsze, Ankie M. [1 ]
van den Broek, Marcel P. H. [1 ]
机构
[1] St Antonius Hosp, Dept Clin Pharm, Utrecht, Netherlands
[2] Univ Utrecht, Dept Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[3] St Antonius Hosp, Dept Internal Med, Utrecht, Netherlands
关键词
appropriateness of prescription; DOAC; medication appropriateness index; medication errors; prescribing patterns; NONVALVULAR ATRIAL-FIBRILLATION; APPROPRIATENESS; METAANALYSIS; ASSOCIATION; MEDICATION; SURGERY; THERAPY;
D O I
10.1111/bcp.14264
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Even though the use of direct oral anticoagulants (DOACs) is safe based on clinical outcomes, drug safety also depends on appropriateness of drug prescription, which is challenging for DOACs since many patient factors need to be considered. The aim of this study was to assess the appropriateness of DOAC prescriptions and to identify risk factors of determinants for inappropriate DOAC prescriptions. Methods A retrospective study in a nonuniversity teaching hospital was performed of hospitalized patients (>= 18 years) who received an initial DOAC prescription between February and August 2018. Appropriateness of prescribing was evaluated on 8 criteria by using a modified version of the medication appropriateness index. Results A total of 770 initial DOAC prescriptions of inpatients were evaluated: 267 patients (34.6%) had at least met 1 inappropriate criterion for a DOAC prescription. The most frequent inappropriate criterion was dosage (17.4%). Of the 4 DOACs, dabigatran (21.6%) and apixaban (21.2%) were mostly inappropriate dosed. In a multivariable analysis, reduced renal function (estimated glomerular filtration rate P <.001), a diagnosis of atrial fibrillation (OR = 1.87;P =.004), and 'prescribed by surgeons' (OR = 1.9;P =.013) were independently associated with inappropriateness of prescribing. Conclusion This study has highlighted a high degree of inappropriate prescribing of DOACs. These results underline the need for targeted interventions to improve DOAC prescribing.
引用
收藏
页码:1567 / 1574
页数:8
相关论文
共 50 条
  • [31] Risk factors for potentially inappropriate prescribing to older patients in primary care
    Projovic, Ivana
    Vukadinovic, Dubravka
    Milovanovic, Olivera
    Jurisevic, Milena
    Pavlovic, Radisa
    Jacovic, Sasa
    Jankovic, Slobodan
    Stefanovic, Srdjan
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (01) : 93 - 107
  • [32] Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team
    Zahar, Jean-Ralph
    Rioux, Christophe
    Girou, Emmanuelle
    Hulin, Anne
    Sauve, Colette
    Bernier-Combes, Alexandra
    Brun-Buisson, Christian
    Lesprit, Philippe
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 58 (03) : 651 - 656
  • [33] Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study
    Miyazaki, Motoyasu
    Matsuo, Koichi
    Uchiyama, Masanobu
    Nakamura, Yoshihiko
    Sakamoto, Yuya
    Misaki, Momoko
    Tokura, Kaoko
    Jimi, Shiro
    Okamura, Keisuke
    Adachi, Sen
    Yamamoto, Tomohiko
    Shirai, Kazuyuki
    Urata, Hidenori
    Imakyure, Osamu
    [J]. JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2020, 6 (01)
  • [34] Potentially Inappropriate Prescribing of Direct-acting Oral Anticoagulants in the Veterans Health Administration
    Rose, Adam J.
    Reisman, Joel I.
    Allen, Arthur L.
    Miller, Donald R.
    [J]. AMERICAN JOURNAL OF PHARMACY BENEFITS, 2016, 8 (04) : E75 - +
  • [35] Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study
    Motoyasu Miyazaki
    Koichi Matsuo
    Masanobu Uchiyama
    Yoshihiko Nakamura
    Yuya Sakamoto
    Momoko Misaki
    Kaoko Tokura
    Shiro Jimi
    Keisuke Okamura
    Sen Adachi
    Tomohiko Yamamoto
    Kazuyuki Shirai
    Hidenori Urata
    Osamu Imakyure
    [J]. Journal of Pharmaceutical Health Care and Sciences, 6
  • [36] Patient Factors Influencing Oral Anticoagulant Prescribing for Atrial Fibrillation After Stroke
    Sterling, Kadieann
    Langhorne, Peter
    Macleod, Mary J.
    Turner, Melanie
    [J]. STROKE, 2020, 51
  • [37] IDENTIFICATION QUALITY OF CHEMOTHERAPY PRESCRIPTIONS FOR CLINICAL TRIAL PATIENTS
    Serrano, C.
    Agustin, M. J.
    Picaza, E.
    Alonso, V
    Idoipe, A.
    Palomo, P.
    Abad, R.
    [J]. ATENCION FARMACEUTICA, 2008, 10 (04): : 222 - 226
  • [38] Genetic and environmental risk factors for oral anticoagulant overdose
    C. Verstuyft
    A. Robert
    S. Morin
    M. A. Loriot
    A. Flahault
    P. Beaune
    C. Funck-Brentano
    P. Jaillon
    L. Becquemont
    [J]. European Journal of Clinical Pharmacology, 2003, 58 : 739 - 745
  • [39] Genetic and environmental risk factors for oral anticoagulant overdose
    Verstuyft, C
    Robert, A
    Morin, S
    Loriot, MA
    Flahault, A
    Beaune, P
    Funck-Brentano, C
    Jaillon, P
    Becquemont, L
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 58 (11) : 739 - 745
  • [40] Subtherapeutic oral anticoagulant therapy: Frequency and risk factors
    Rombouts, Eva K.
    Rosendaal, Frits R.
    van der Meer, Felix J. M.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2009, 101 (03) : 552 - 556